loading page

Myelodysplastic Syndrome with Excess of Blasts - Long Term Partial Remission with Low Dose Prednisone, G-CSF and Epoetin Alfa
  • Anwarul Islam
Anwarul Islam
Buffalo General Medical Center

Corresponding Author:[email protected]

Author Profile

Abstract

We have used low-dose prednisone, in conjunction with granulocyte, colony-stimulating factor (G-CSF) and erythropoietin, to treat an elderly patient with myelodysplastic syndrome (MDS) with an excess of blasts. Our findings indicate that such treatment is safe and may be effective in the long term survival of patients with high-risk MDS.
09 May 2021Submitted to Clinical Case Reports
11 May 2021Submission Checks Completed
11 May 2021Assigned to Editor
29 May 2021Reviewer(s) Assigned
09 Jun 2021Review(s) Completed, Editorial Evaluation Pending
10 Jun 2021Editorial Decision: Revise Minor
14 Jun 20211st Revision Received
14 Jun 2021Submission Checks Completed
14 Jun 2021Assigned to Editor
14 Jun 2021Review(s) Completed, Editorial Evaluation Pending
23 Jun 2021Editorial Decision: Revise Minor
17 Jul 20212nd Revision Received
17 Jul 2021Submission Checks Completed
17 Jul 2021Assigned to Editor
17 Jul 2021Review(s) Completed, Editorial Evaluation Pending
09 Aug 2021Editorial Decision: Accept